Clinical Trials Directory

Trials / Completed

CompletedNCT03436108

Bisphenol Role in the Pathogenesis of PCOS

Role of Bisphenol A (BPA) in the Pathogenesis of the Polycystic Ovary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
220 (actual)
Sponsor
Aljazeera Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Polycystic ovary syndrome (PCOS) is the most common and the most heterogeneous endocrine disorder in premenopausal women. Its prevalence is estimated from 5 to 10% depending on the diagnosis' criteria . Apart from signs of hyperandrogenism such as acne, hirsutism and hair loss; women with PCOS usually present with menstrual irregularities and fertility problems ..

Detailed description

Bisphenol A is formed from acetone and phenol, it is used in production of epoxy resin, polyster resins and polyvarbonate resins. Epoxy resins are used in plastics, adhesives, and structural composites . Humans are at the end of the food chain, thus they are exposed to the highest doses of these compounds. EDs have been detected in human adipose tissue and biological fluids such as: serum, urine, milk and amniotic fluid . Additionally, it has been proven that BPA can also directly stimulate androgen synthesis in the ovarian theca-interstitial cells. A correlation between increased serum testosterone levels observed in women with PCOS with serum BPA concentrations has also been found .

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMeasurement of Bisphenol in urineto see level of this material in blood of women

Timeline

Start date
2019-02-10
Primary completion
2019-12-01
Completion
2020-01-20
First posted
2018-02-19
Last updated
2022-01-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03436108. Inclusion in this directory is not an endorsement.